Skye Bioscience, Inc. (SKYE) Financials
SKYE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 11.0 million | 11.5 million |
| March 31, 2026 | 19.4 million | 10.4 million |
| Dec. 31, 2025 | 28.3 million | 8.3 million |
| Sept. 30, 2025 | 41.3 million | 8.5 million |
SKYE Free Cash Flow and Stock based compensation
No data available :(
SKYE Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| June 30, 2026 | -10.8 million |
| March 31, 2026 | -12.5 million |
| Dec. 31, 2025 | 11.1 billion |
| Sept. 30, 2025 | -12.8 million |
SKYE Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 10.1 million | - | - |
| March 31, 2026 | 17.1 million | - | 60980 |
| Dec. 31, 2025 | 25.7 million | - | 273646 |
| Sept. 30, 2025 | 35.3 million | - | 321845 |
SKYE Shares Outstanding
SKYE Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 3.9 million | 3.9 million | - |
| March 31, 2026 | 3 | 7.8 million | 4.7 million | - |
| Dec. 31, 2025 | 3 | 11.5 million | 3.4 million | - |
| Sept. 30, 2025 | 5 | 9.4 million | 3.9 million | - |
SKYE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 172886 |
| Dec. 31, 2025 | - | 180009 |
| Sept. 30, 2025 | - | - |
SKYE
Price: $0.28
52 week price:
Earnings Per Share: -1.08 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 12.7 million